ADVFN - ニュース

US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

銘柄名/コード:

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/06	20 : 35	Alliance News	COMMODITIES MARKET: Oil eases slightly despite Saudi hikes; gold rises
2024/05/06	20 : 35	PR Newswire (Canada)	Test du système En Alerte prévu le 8 mai
2024/05/06	20 : 35	PR Newswire (Canada)	Test of Alert Ready, Canada's national public alerting system, scheduled on May 8
2024/05/06	20 : 34	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:CUBE	CubeSmart
2024/05/06	20 : 34	PR Newswire (US)	TAILG Unveils 19 E-bikes at 2024 CHINA CYCLE
2024/05/06	20 : 33	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NEP	NextEra Energy Partners LP
2024/05/06	20 : 33	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:AMR	Alpha Metallurgical Resources Inc
2024/05/06	20 : 33	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:JLL	Jones Lang LaSalle Inc
2024/05/06	20 : 33	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:AGM	Federal Agricultural Mortgage Corporation
2024/05/06	20 : 33	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:TSN	Tyson Foods
2024/05/06	20 : 33	Business Wire	Genesis Energy, L.P. Announces Public Offering of Senior Notes	NYSE:GEL	Genesis Energy LP
2024/05/06	20 : 32	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:BOWL	Bowlero Corp
2024/05/06	20 : 32	Edgar (US Regulatory)	Form 424B7 - Prospectus [Rule 424(b)(7)]	NASDAQ:SKWD	Skyward Specialty Insurance Group Inc
2024/05/06	20 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:TSN	Tyson Foods
2024/05/06	20 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:BOWL	Bowlero Corp
2024/05/06	20 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GOSS	Gossamer Bio Inc
2024/05/06	20 : 30	GlobeNewswire Inc.	Kforce Inc. Announces Transfer of Listing of Common Stock to the New York Stock Exchange	NASDAQ:KFRC	Kforce Inc
2024/05/06	20 : 30	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:NBSE	NeuBase Therapeutics Inc
2024/05/06	20 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KFRC	Kforce Inc
2024/05/06	20 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:AESI	New Atlas Holdco Inc
2024/05/06	20 : 30	Business Wire	Thryv to Participate in Upcoming Investor Conferences	NASDAQ:THRY	Thryv Holdings Inc
2024/05/06	20 : 30	Business Wire	Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other Indications	NASDAQ:GOSS	Gossamer Bio Inc
2024/05/06	20 : 30	GlobeNewswire Inc.	ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants
2024/05/06	20 : 30	GlobeNewswire Inc.	Metasphere Labs Announces a Follow-Up Event Regarding Bitcoin’s Defi Revolution	H1N
2024/05/06	20 : 30	GlobeNewswire Inc.	Spectral Medical Provides April Tigris Trial Update	TSX:EDT	Spectral Medical Inc
2024/05/06	20 : 30	Business Wire	Distribution Solutions Group to Participate in Two Conferences: Barrington Research Virtual Spring Investment Conference; KeyBanc Capital Markets Industrials & Basic Materials Conference	NASDAQ:DSGR	Distribution Solutions Group Inc
2024/05/06	20 : 30	GlobeNewswire Inc.	Tyson Foods Reports Second Quarter 2024 Results	NYSE:TSN	Tyson Foods
2024/05/06	20 : 30	GlobeNewswire Inc.	Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/05/06	20 : 30	Business Wire	Lomiko Announces Excellent Results from La Loutre Graphite Testing with CRITM Grant and Corporate Update	TSXV:LMR	Lomiko Metals Inc
2024/05/06	20 : 30	GlobeNewswire Inc.	Plus Therapeutics Announces Private Placement Financing of up to $18 Million	NASDAQ:PSTV	Plus Therapeutics Inc

1 2 3 4 5 6 7 8 9 10 次へ >>

Invesco QQQ Trust Series 1

Verizon Communications

Deutsche Telekom (QX)

BNP Paribas (QX)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約